NumFin

Nuo Therapeutics, Inc.

Simbol: AURX

PNK

0.8

USD

Tržna cena danes

  • -10.7721

    Razmerje P/E

  • -0.1077

    Razmerje PEG

  • 35.39M

    Kapaciteta MRK

  • 0.00%

    Donos DIV

Nuo Therapeutics, Inc. (AURX) Finančni izkazi

Download
LetniČetrtletno
LinearnoLog
Na grafu so prikazane privzete številke v dinamiki za Nuo Therapeutics, Inc. (AURX). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

LetniČetrtletno
10Y20Y30Y40Y

Bilanca stanja

Če pogledamo fiskalno pot podjetja Nuo Therapeutics, Inc., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

balance-sheet.row.cash-and-short-term-investments

00.92.10.1
0.2
0.2
0.6
0.7
2.7
1
15.9
3.3
2.7
2.3
0.7
2.2
4
5.1
4.7
3.1
3.3
0.8
0.9
0.2
2.1
0.1

balance-sheet.row.short-term-investments

0000
0
0.2
0
0
0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

00.30.10
0
0
0
0.1
0.7
1
1.9
3.9
1.7
1.5
1.2
0.2
0.5
0.7
1
0.4
0.3
0.2
0.2
0
0.2
0

balance-sheet.row.inventory

00.20.20
0
0
0
0
0.1
0.3
0.6
1.1
1.2
0.5
0.6
166731
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

00.20.20
0
0
0.2
0.3
0.3
0.8
2.3
0
0.1
0.8
1
0.2
0
0.1
0
0
0.3
0.2
0.3
0.3
0.1
0

balance-sheet.row.total-current-assets

01.62.60.1
0.2
0.2
0.9
1.2
3.8
3
21.9
10
6.4
5.2
3.5
2.5
4.7
6.1
5.8
3.8
3.9
1.2
1.4
0.5
2.5
0.2

balance-sheet.row.property-plant-equipment-net

00.30.40
0
0
0.1
0.2
0.5
1.1
0.9
0.9
2.4
1
1.3
0.1
0.1
0
0
0.1
0.2
0.2
0.3
0
0.5
0.1

balance-sheet.row.goodwill

0000
0
0
0
0
2.1
0
1.1
1.1
1.1
0.7
0.7
0
0
2
2
2
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0000
0
0
0
0
7.8
2.5
28.7
33.8
34.1
2.9
3.2
0
0
1.7
1.8
2
4.1
4.2
4.4
0.6
0
0

balance-sheet.row.goodwill-and-intangible-assets

0000
0
0
0
0
9.9
2.5
29.9
34.9
35.3
3.6
3.9
0
0
3.7
3.8
4
4.1
4.2
4.4
0.6
0
0

balance-sheet.row.long-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0000
0
0
0
0
0.3
0.4
3.5
0.5
0.2
0.3
0.2
0
0
0.2
0.6
0
0
0
0
0.1
0.9
0

balance-sheet.row.total-non-current-assets

00.30.40
0
0
0.1
0.2
10.7
4
34.3
36.3
37.9
4.9
5.4
0.1
0.1
3.9
4.4
4.1
4.3
4.5
4.7
0.7
1.4
0.1

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

01.930.1
0.2
0.2
1
1.4
14.5
7.1
56.2
46.3
44.3
10.1
8.9
2.6
4.8
10
10.2
7.9
8.2
5.7
6.2
1.2
3.9
0.3

balance-sheet.row.account-payables

00.40.40.5
0.5
0.5
0.4
0.4
0.4
1.1
1.9
3.4
1.4
1.2
3.6
1
1.3
0.1
1.2
1.1
1
0.6
0.7
0.1
0.8
0.1

balance-sheet.row.short-term-debt

00.10.10
0
0.7
0.3
0
-0.1
35
2.5
1.8
0
0
1.5
0
0
0.8
0
0
0
0
0
0.2
0
0.2

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

00.20.30
0
0
0
0
0
0
0.3
3.8
2.1
2.1
2
0
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

0000
0
0
0
0
0
0.6
1
1.4
-0.7
0
0
0
0
197344
191475
263745
0
0
0
0.6
0
0.1

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

00.30.10.1
0.1
0.1
0.3
0.5
1
5
3.7
2.9
1.4
1.3
0.1
0
0
0
0
0
0.2
0.1
0
0.1
-0.1
0

balance-sheet.row.total-non-current-liabilities

00.20.30
0
0
0.7
0
0.2
1.4
31.8
9.4
3.5
3.7
3.8
1
0.1
0.2
0.4
0.3
0.4
0.4
0.6
10
1.8
1.7

balance-sheet.row.other-liabilities

0000
0
0
-0.7
0
0
0
0
0
0
0
0
-1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

00.20.30
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

00.80.90.7
0.7
0.7
1.1
0.9
1.6
43.6
40.3
19.9
6.3
6.8
9
1
1.7
1.4
1.7
1.5
1.7
1.3
1.5
10.8
2.9
2.1

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0000
0
0
0
0
0
0
0.9
0.4
0.5
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

0-29.9-26.8-23.5
-23.5
-23.5
-22.2
-20.7
-5.2
-162.9
-110.1
-91.2
-71
-51.2
-47.7
-42.5
-39.1
-31.4
-26.6
-24.3
-17.7
-6.5
-2.1
-60.8
-39.6
-6.2

balance-sheet.row.accumulated-other-comprehensive-income-loss

0000
0
0
0
0
-0.1
0
0
0
0
0
0
0
0
0
-0.6
-0.2
-1.4
-1.4
-0.2
0
0
0

balance-sheet.row.other-total-stockholders-equity

0312923
23
23
22.1
21.2
18.2
126.3
125.2
117.1
108.5
54.5
47.6
44.1
42.2
40
35.8
31
25.7
12.4
6.9
51.3
40.6
4.4

balance-sheet.row.total-stockholders-equity

012.2-0.5
-0.5
-0.5
-0.1
0.5
12.9
-36.6
16
26.3
38
3.3
-0.1
1.5
3.1
8.6
8.5
6.4
6.5
4.5
4.7
-9.6
1
-1.8

balance-sheet.row.total-liabilities-and-stockholders-equity

01.930.1
0.2
0.2
1
1.4
14.5
7.1
56.2
46.3
44.3
10.1
8.9
2.6
4.8
10
10.2
7.9
8.2
5.7
6.2
1.2
3.9
0.3

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

012.2-0.5
-0.5
-0.5
-0.1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0000
0
0.2
0
0
0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

00.30.30
0
0.7
0.3
0
0
35
0.3
5.6
2.1
2.1
3.5
0
0
0
0
0
0
0
0
0.2
0
0.2

balance-sheet.row.net-debt

0-0.7-1.7-0.1
-0.2
0.5
-0.3
-0.7
-2.7
34.1
-15.6
2.3
-0.5
-0.1
2.9
-2.1
-4
-5.1
-4.7
-3.1
-3.3
-0.8
-0.9
0
-2.1
0.1

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Nuo Therapeutics, Inc. opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

cash-flows.row.net-income

0-3.2-3.20
0
0
-1.5
-15
0
-52.8
-18.9
-20.2
-19.8
-3.5
-6.8
-3.4
-7.7
-5
-2.3
-6.5
-8.1
-4.1
-2
-21.2
-33.3
-6.2

cash-flows.row.depreciation-and-amortization

00.10.10
0
0.1
0.1
1.1
0
0.7
0.6
1.1
1.2
0.6
0.4
0
0.2
0.2
0.2
2.2
3.3
1.2
0.1
0.5
0.1
0

cash-flows.row.deferred-income-tax

0000
0
-0.4
-0.2
0
0
-0.1
0
0
0
0
0
-0.4
3.5
-1014966
-129794
-1526088
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

00013936
0.3
0.1
0
0.1
0
0.8
1.3
0.7
2
0.3
0.4
0.4
0.7
1014966
129794
1526088
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-0.3-0.50
0
0
0.7
-0.3
0
0.2
0.8
5.2
-1.5
-1.3
1.6
-0.3
0.8
0.4
-0.8
-0.1
0.1
0.1
-0.6
0.5
0.4
0.1

cash-flows.row.account-receivables

0-0.3-0.10
0
0
0.3
277.1
0
695612
2005581
-2268104
-260510
-0.9
-1
0.3
0.2
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

00-0.20
0
0
0
0
0
0.3
0.5
0.1
-0.6
0.1
0.5
287430.7
-377027.4
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

0000
0
0
0.1
0
0
-0.8
-1.5
5206301
-83767
-1055983
2356062
-287431
377028
-190818
98217
94678
0
0
0
0
0
0

cash-flows.row.other-working-capital

00-0.20
0
0
0.4
-277.4
0
-695611.2
-2005579.2
-2938191.9
344276.1
1055982.5
-2356059.9
-0.3
-0.1
190818.4
-98217.8
-94678.1
0.1
0.1
-0.6
0.5
0.4
0

cash-flows.row.other-non-cash-items

00.2-0.1-13936
-0.3
-0.1
0
9.2
0
36.7
-1.2
1.9
6.7
-0.3
0.8
0.4
0
2.3
1.2
0.2
0
0.1
0.5
17.4
28.3
5.4

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

00-0.10
0
0
0
0
0
-0.7
-0.5
-0.8
-2.1
-0.1
-0.8
0
-0.1
0
0
0
-0.1
0
-0.3
0
-0.6
0

cash-flows.row.acquisitions-net

0000
0
0
0
0
0
0
0
0
0
0
-2
0
0
0
0
0
0
0
0
-2.4
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
-0.1
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0000
0
0
0
0.1
0
0.1
0.1
2.1
0.5
0.1
0.1
0
0
0
0
0.1
0
0
0
0.2
-0.8
0.4

cash-flows.row.net-cash-used-for-investing-activites

00-0.10
0
0
0
0.1
0
-0.6
-0.3
1.4
-1.6
0
-2.7
-0.1
-0.1
0
0
0.1
-0.1
0
-0.3
-2.3
-1.4
0.4

cash-flows.row.debt-repayment

0000
0
0
0
0
0
0
-6.2
-1
-9.5
-2.6
-0.5
0
0
0
-11035
0
0
0
0
0
-0.2
-0.2

cash-flows.row.common-stock-issued

024.51.4
0.2
0
0.5
2.9
0
0
3.7
5.5
9.5
3.8
1.9
1.4
1.4
2.6
3.2
4
7.2
2.7
3.2
0
8
0.4

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
-0.2
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-11035
-0.1
0
0
0
0
0
0

cash-flows.row.other-financing-activites

024.51373092
0.2
0.3
0.3
0
0
0
33
6.2
13.6
4.7
3.4
0
0
0
22070
0
0
-0.1
-0.1
3.2
0
0.2

cash-flows.row.net-cash-used-provided-by-financing-activities

024.51373092
0.2
0.3
0.8
2.9
0
0
30.4
10.7
13.4
5.8
4.8
1.4
1.4
2.6
3.2
3.9
7.2
2.6
3.1
3.2
7.8
0.4

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-1.20.70
0
0
-0.1
-1.9
0
-15
12.7
0.7
0.4
1.6
-1.5
-1.9
-1.1
0.5
1.5
-0.2
2.5
-0.1
0.9
-1.9
2
0.1

cash-flows.row.cash-at-end-of-period

00.92.10.1
0.2
0.2
0.6
0.7
0
0.9
15.9
3.3
2.6
2.2
0.6
2.1
4
5.1
4.7
3.1
3.3
0.8
1
0.2
2.1
0.1

cash-flows.row.cash-at-beginning-of-period

02.11.40.2
0.2
0.2
0.7
2.6
0
15.9
3.3
2.6
2.2
0.6
2.1
4
5.1
4.7
3.1
3.3
0.8
0.9
0.1
2.1
0.1
0

cash-flows.row.operating-cash-flow

0-3.2-3.70
0
0
-0.9
-4.9
0
-14.4
-17.4
-11.4
-11.4
-4.2
-3.5
-3.2
-2.5
-2.1
-1.7
-4.2
-4.7
-2.7
-1.9
-2.8
-4.4
-0.7

cash-flows.row.capital-expenditure

00-0.10
0
0
0
0
0
-0.7
-0.5
-0.8
-2.1
-0.1
-0.8
0
-0.1
0
0
0
-0.1
0
-0.3
0
-0.6
0

cash-flows.row.free-cash-flow

0-3.2-3.80
0
0
-0.9
-4.9
0
-15.1
-17.9
-12.2
-13.5
-4.3
-4.3
-3.3
-2.6
-2.2
-1.7
-4.2
-4.8
-2.7
-2.2
-2.9
-5
-0.7

Vrstica izkaza poslovnega izida

Prihodki Nuo Therapeutics, Inc. so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja AURX znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

income-statement-row.row.total-revenue

00.60.10
0
0.1
1.4
0.7
2205
11.5
7.8
11.6
10.6
7.2
3.9
2.1
2.1
1.9
1.9
1.5
1.1
1.1
0.4
0
0.3
0

income-statement-row.row.cost-of-revenue

00.100
0
0.1
0.2
1.1
1613
8
6.8
8.5
3.9
2.7
1.6
0.5
0.6
0.9
1
0.9
0.7
0.8
0.1
0
0.1
0

income-statement-row.row.gross-profit

00.50.10
0
0
1.2
-0.4
592
3.5
1
3.1
6.6
4.5
2.3
1.6
1.5
1.1
0.9
0.6
0.4
0.3
0.3
0
0.3
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0000
0
0
0
0.6
0
0
0
0
-2
1473670
1930655
2187696
6018366
1028137
1528361
4706508
0
0
0.4
3.7
31.9
3.2

income-statement-row.row.operating-expenses

03.73.40.1
0.4
1
2.7
5.9
0
17.8
19.7
21.2
19.5
8
7.7
5.1
5.8
6.4
5.1
8.1
8.6
4.5
2.4
5.5
33.7
3.5

income-statement-row.row.cost-and-expenses

03.83.40.1
0.4
1.1
2.9
7
1613
25.8
26.5
29.7
23.5
10.8
9.3
5.5
6.4
7.3
6.1
9
9.3
5.2
2.4
5.5
33.8
3.5

income-statement-row.row.interest-income

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3
0.2
0.1
0.1
0
0
0
0.2
0

income-statement-row.row.interest-expense

000-48390
0
0.2
0
0
0
3.8
3.4
1.7
1
1
-0.8
0
0.2
-0.3
-1.9
-6.5
0
0
0
5.6
0
-6.2

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

000.1287189
0.3
-0.2
0
-8.7
0
-34.9
3.3
-0.5
-5.8
1.1
-0.6
0
-3.5
0
1.7
0.8
0
0
-0.3
11.1
-0.4
-2.7

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0000
0
0
0
0.6
0
0
0
0
-2
1473670
1930655
2187696
6018366
1028137
1528361
4706508
0
0
0.4
3.7
31.9
3.2

income-statement-row.row.total-operating-expenses

000.1287189
0.3
-0.2
0
-8.7
0
-34.9
3.3
-0.5
-5.8
1.1
-0.6
0
-3.5
0
1.7
0.8
0
0
-0.3
11.1
-0.4
-2.7

income-statement-row.row.interest-expense

000-48390
0
0.2
0
0
0
3.8
3.4
1.7
1
1
-0.8
0
0.2
-0.3
-1.9
-6.5
0
0
0
5.6
0
-6.2

income-statement-row.row.depreciation-and-amortization

00.10.10.1
0.1
0
0.1
1.1
0
0.7
0.6
1.1
1.2
0.6
0.4
0
0.2
0.2
0.2
2.2
3.3
1.2
0.1
0.5
0.1
0

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-3.2-3.3-0.1
-0.4
-1
-1.5
-15.5
592
-41.3
-23.4
-18.1
-12.9
-3.5
-5.4
-3.4
-7.9
-5.4
-4.2
-7.4
-8.2
-4.1
-2
-5.4
-33.5
-6.2

income-statement-row.row.income-before-tax

0-3.2-3.2-0.1
-0.1
-1.2
-1.5
-15
0
-52.9
-18.9
-20.2
-19.8
-3.5
-6.8
-3.4
-7.7
-5
-2.3
-6.5
-8.1
-4.1
-2
-21.2
-33.3
-6.2

income-statement-row.row.income-tax-expense

00-0.1287188.9
0
0.2
0
-0.6
0
-0.1
0
0
0
0
0
0
-0.2
-0.3
-1.9
6.5
8.1
4.1
2
21.2
33.3
6.2

income-statement-row.row.net-income

0-3.2-3-0.1
-0.1
-1.4
-1.5
-15
0
-52.8
-18.9
-20.2
-19.8
-3.5
-6.8
-3.4
-7.7
-5
-2.3
-6.5
-8.1
-4.1
-2
-21.2
-33.3
-6.2
Podobne delnice
Morda vas zanima tudi:
MRVI
Maravai LifeSciences Holdings, Inc..
9.86 USD
NASDAQ
CMRA
Comera Life Sciences Holdings, Inc..
0.02684 USD
NASDAQ
GUBRA.CO
Gubra A/S.
338 DKK
CPH
T5O.DE
CytoTools AG.
0.406 EUR
XETRA
6826.HK
Shanghai Haohai Biological Technology Co., Ltd..
42 HKD
HKSE
PPBT
Purple Biotech Ltd..
0.67 USD
NASDAQ
SPHRF
Starpharma Holdings Limited.
0.0774 USD
PNK

Pogosto zastavljeno vprašanje

Kaj je Nuo Therapeutics, Inc. (AURX) skupna sredstva?

Nuo Therapeutics, Inc. (AURX) skupna sredstva so 1877880.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.793.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je -0.074.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -5.214.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so -5.206.

Kaj je Nuo Therapeutics, Inc. (AURX) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je -3171436.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 255592.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 3650707.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 0.000.